NFATC1 and neoplasm: For new tumor event index and progressive disease rate of CD274, EGFR, RAF1, PIK3CA, MTOR, NFKB1, TRAF6, HIF1A, and NFATC1 genes, the patients in the high expression level group, new tumor event rate, and disease progression rate were not increased and even decreased by received radiotherapy.